{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,26]],"date-time":"2025-09-26T00:04:28Z","timestamp":1758845068041,"version":"3.44.0"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,7,8]],"date-time":"2025-07-08T00:00:00Z","timestamp":1751932800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,7,8]],"date-time":"2025-07-08T00:00:00Z","timestamp":1751932800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Endocrine"],"DOI":"10.1007\/s12020-025-04342-4","type":"journal-article","created":{"date-parts":[[2025,7,10]],"date-time":"2025-07-10T09:16:09Z","timestamp":1752138969000},"page":"39-48","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Comparison of mortality and cardiovascular morbidity following treatment for hyperthyroidism: A systematic review and bayesian network meta-analysis"],"prefix":"10.1007","volume":"90","author":[{"ORCID":"https:\/\/orcid.org\/0009-0003-0637-0387","authenticated-orcid":false,"given":"Artur","family":"de Oliveira Macena L\u00f4bo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-3006-5489","authenticated-orcid":false,"given":"Luis Eduardo Rodrigues","family":"Sobreira","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-7032-8167","authenticated-orcid":false,"given":"Danilo Monteiro","family":"Ribeiro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-2008-2777","authenticated-orcid":false,"given":"Isabela Junger Meirelles","family":"Aguiar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0706-6929","authenticated-orcid":false,"given":"Francinny Alves","family":"Kelly","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,7,8]]},"reference":[{"key":"4342_CR1","doi-asserted-by":"publisher","first-page":"1472","DOI":"10.1001\/jama.2023.19052","volume":"330","author":"SY Lee","year":"2023","unstructured":"S.Y. Lee, E.N. Pearce, Hyperthyroidism: A review. JAMA 330, 1472\u20131483 (2023). https:\/\/doi.org\/10.1001\/jama.2023.19052.","journal-title":"JAMA"},{"key":"4342_CR2","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1038\/nrendo.2018.18","volume":"14","author":"PN Taylor","year":"2018","unstructured":"P.N. Taylor, D. Albrecht, A. Scholz et al., Global epidemiology of hyperthyroidism and hypothyroidism. Nat. Rev. Endocrinol. 14, 301\u2013316 (2018). https:\/\/doi.org\/10.1038\/nrendo.2018.18.","journal-title":"Nat. Rev. Endocrinol."},{"key":"4342_CR3","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1038\/nrcardio.2016.174","volume":"14","author":"A Jabbar","year":"2017","unstructured":"A. Jabbar, A. Pingitore, S.H.S. Pearce et al., Thyroid hormones and cardiovascular disease. Nat. Rev. Cardiol. 14, 39\u201355 (2017). https:\/\/doi.org\/10.1038\/nrcardio.2016.174.","journal-title":"Nat. Rev. Cardiol."},{"key":"4342_CR4","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1056\/NEJM200102153440707","volume":"344","author":"I Klein","year":"2001","unstructured":"I. Klein, K. Ojamaa, Thyroid hormone and the cardiovascular system. N. Engl. J. Med. 344, 501\u2013509 (2001). https:\/\/doi.org\/10.1056\/NEJM200102153440707.","journal-title":"N. Engl. J. Med."},{"key":"4342_CR5","doi-asserted-by":"publisher","first-page":"1675","DOI":"10.1001\/archinte.164.15.1675","volume":"164","author":"L Frost","year":"2004","unstructured":"L. Frost, P. Vestergaard, L. Mosekilde, Hyperthyroidism and risk of atrial fibrillation or flutter: A population-based study. Arch. Intern. Med. 164, 1675\u20131678 (2004). https:\/\/doi.org\/10.1001\/archinte.164.15.1675.","journal-title":"Arch. Intern. Med."},{"key":"4342_CR6","doi-asserted-by":"publisher","first-page":"961","DOI":"10.1161\/STROKEAHA.109.577742","volume":"41","author":"J-J Sheu","year":"2010","unstructured":"J.-J. Sheu, J.-H. Kang, H.-C. Lin, H.-C. Lin, Hyperthyroidism and risk of ischemic stroke in young adults: A 5-year follow-up study. Stroke 41, 961\u2013966 (2010). https:\/\/doi.org\/10.1161\/STROKEAHA.109.577742.","journal-title":"Stroke"},{"key":"4342_CR7","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1530\/EJE-16-0576","volume":"176","author":"OM Dekkers","year":"2017","unstructured":"O.M. Dekkers, E. Horv\u00e1th-Puh\u00f3, S.C. Cannegieter et al., Acute cardiovascular events and all-cause mortality in patients with hyperthyroidism: A population-based cohort study. Eur. J. Endocrinol. 176, 1\u20139 (2017). https:\/\/doi.org\/10.1530\/EJE-16-0576.","journal-title":"Eur. J. Endocrinol."},{"key":"4342_CR8","doi-asserted-by":"publisher","first-page":"1343","DOI":"10.1089\/thy.2016.0229","volume":"26","author":"DS Ross","year":"2016","unstructured":"D.S. Ross, H.B. Burch, D.S. Cooper et al., 2016 American thyroid association guidelines for diagnosis and management of hyperthyroidism and other causes of thyrotoxicosis. Thyroid 26, 1343\u20131421 (2016). https:\/\/doi.org\/10.1089\/thy.2016.0229.","journal-title":"Thyroid"},{"key":"4342_CR9","doi-asserted-by":"publisher","first-page":"906","DOI":"10.1016\/S0140-6736(16)00278-6","volume":"388","author":"SD Leo","year":"2016","unstructured":"S.D. Leo, S.Y. Lee, L.E. Braverman, Hyperthyroidism. Lancet 388, 906\u2013918 (2016). https:\/\/doi.org\/10.1016\/S0140-6736(16)00278-6.","journal-title":"Lancet"},{"key":"4342_CR10","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1002\/wjs.12066","volume":"48","author":"X Liu","year":"2024","unstructured":"X. Liu, C.K.H. Wong, T. Wu et al., A comparison of cardiovascular disease, cancer, mortality, and Graves\u2019 ophthalmopathy following treatment for hyperthyroidism: A Bayesian network meta-analysis. World J. Surg. 48, 393\u2013407 (2024). https:\/\/doi.org\/10.1002\/wjs.12066.","journal-title":"World J. Surg."},{"key":"4342_CR11","doi-asserted-by":"publisher","first-page":"777","DOI":"10.7326\/M14-2385","volume":"162","author":"B Hutton","year":"2015","unstructured":"B. Hutton, G. Salanti, D.M. Caldwell et al., The PRISMA extension statement for reporting of systematic reviews incorporating network meta-analyses of health care interventions: Checklist and explanations. Ann. Intern. Med. 162, 777\u2013784 (2015). https:\/\/doi.org\/10.7326\/M14-2385.","journal-title":"Ann. Intern. Med."},{"key":"4342_CR12","doi-asserted-by":"publisher","DOI":"10.1186\/s13643-016-0384-4","volume":"5","author":"M Ouzzani","year":"2016","unstructured":"M. Ouzzani, H. Hammady, Z. Fedorowicz, A. Elmagarmid, Rayyan-a web and mobile app for systematic reviews. Syst. Rev. 5, 210 (2016). https:\/\/doi.org\/10.1186\/s13643-016-0384-4.","journal-title":"Syst. Rev."},{"key":"4342_CR13","doi-asserted-by":"publisher","DOI":"10.1186\/1745-6215-8-16","volume":"8","author":"JF Tierney","year":"2007","unstructured":"J.F. Tierney, L.A. Stewart, D. Ghersi et al., Practical methods for incorporating summary time-to-event data into meta-analysis. Trials 8, 16 (2007). https:\/\/doi.org\/10.1186\/1745-6215-8-16.","journal-title":"Trials"},{"key":"4342_CR14","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2288-10-54","volume":"10","author":"BS Woods","year":"2010","unstructured":"B.S. Woods, N. Hawkins, D.A. Scott, Network meta-analysis on the log-hazard scale, combining count and hazard ratio statistics accounting for multi-arm trials: a tutorial. BMC Med. Res. Methodol. 10, 54 (2010). https:\/\/doi.org\/10.1186\/1471-2288-10-54.","journal-title":"BMC Med. Res. Methodol."},{"key":"4342_CR15","doi-asserted-by":"publisher","first-page":"i4919","DOI":"10.1136\/bmj.i4919","volume":"355","author":"JA Sterne","year":"2016","unstructured":"J.A. Sterne, M.A. Hern\u00e1n, B.C. Reeves et al., ROBINS-I: A tool for assessing risk of bias in non-randomised studies of interventions. BMJ 355, i4919 (2016). https:\/\/doi.org\/10.1136\/bmj.i4919.","journal-title":"BMJ"},{"key":"4342_CR16","unstructured":"M. Plummer, JAGS Version 4.3.0 User Manual, Technical Report, International Agency for Research on Cancer, Lyon, France (2017). http:\/\/www.stat.yale.edu\/~jtc5\/238\/materials\/jags_4.3.0_manual_with_distributions.pdf."},{"key":"4342_CR17","doi-asserted-by":"publisher","DOI":"10.1186\/s12874-019-0829-2","volume":"19","author":"A B\u00e9liveau","year":"2019","unstructured":"A. B\u00e9liveau, D.J. Boyne, J. Slater et al., BUGSnet: An R package to facilitate the conduct and reporting of Bayesian network meta-analyses. BMC Med. Res. Methodol. 19, 196 (2019). https:\/\/doi.org\/10.1186\/s12874-019-0829-2.","journal-title":"BMC Med. Res. Methodol."},{"key":"4342_CR18","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1080\/10618600.1998.10474787","volume":"7","author":"S Brooks","year":"1998","unstructured":"S. Brooks, A. Gelman, General methods for monitoring convergence of iterative simulations. J. Comput. Graph. Stat. 7, 434\u2013455 (1998). https:\/\/doi.org\/10.1080\/10618600.1998.10474787.","journal-title":"J. Comput. Graph. Stat."},{"key":"4342_CR19","unstructured":"S. Dias, N.J. Welton, A.J. Sutton et al., NICE DSU technical support document 4: Inconsistency in networks of evidence based on randomised controlled trials. National Institute for Health and Care Excellence (NICE), London. (2014) https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK310372\/."},{"key":"4342_CR20","doi-asserted-by":"publisher","first-page":"1869","DOI":"10.1210\/jc.2012-3459","volume":"98","author":"K Boelaert","year":"2013","unstructured":"K. Boelaert, P. Maisonneuve, B. Torlinska, J.A. Franklyn, Comparison of mortality in hyperthyroidism during periods of treatment with thionamides and after radioiodine. J. Clin. Endocrinol. Metab. 98, 1869\u20131882 (2013). https:\/\/doi.org\/10.1210\/jc.2012-3459.","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"4342_CR21","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1002\/bjs.10665","volume":"105","author":"P Giesecke","year":"2018","unstructured":"P. Giesecke, V. Frykman, G. Wallin et al., All-cause and cardiovascular mortality risk after surgery versus radioiodine treatment for hyperthyroidism. Br. J. Surg. 105, 279\u2013286 (2018). https:\/\/doi.org\/10.1002\/bjs.10665.","journal-title":"Br. J. Surg."},{"key":"4342_CR22","doi-asserted-by":"publisher","first-page":"4281","DOI":"10.2147\/IJGM.S484910","volume":"17","author":"Y Guo","year":"2024","unstructured":"Y. Guo, D. Huang, J. Sun et al., Radioactive Iodine-131 therapy reduced the risk of MACEs and all-cause mortality in elderly with hyperthyroidism combined with type 2 diabetes. Int. J. Gen. Med. 17, 4281\u20134295 (2024). https:\/\/doi.org\/10.2147\/IJGM.S484910.","journal-title":"Int. J. Gen. Med."},{"key":"4342_CR23","doi-asserted-by":"publisher","first-page":"1197","DOI":"10.1097\/SLA.0000000000004828","volume":"273","author":"X Liu","year":"2021","unstructured":"X. Liu, C.K.H. Wong, W.W.L. Chan et al., Outcomes of Graves\u2019 disease patients following antithyroid drugs, radioactive iodine, or thyroidectomy as the first-line treatment. Ann. Surg. 273, 1197\u20131206 (2021). https:\/\/doi.org\/10.1097\/SLA.0000000000004828.","journal-title":"Ann. Surg."},{"key":"4342_CR24","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1016\/S2213-8587(19)30059-2","volume":"7","author":"OE Okosieme","year":"2019","unstructured":"O.E. Okosieme, P.N. Taylor, C. Evans et al., Primary therapy of Graves\u2019 disease and cardiovascular morbidity and mortality: A linked-record cohort study. Lancet Diabetes Endocrinol. 7, 278\u2013287 (2019). https:\/\/doi.org\/10.1016\/S2213-8587(19)30059-2.","journal-title":"Lancet Diabetes Endocrinol."},{"key":"4342_CR25","doi-asserted-by":"publisher","first-page":"e240904","DOI":"10.1001\/jamanetworkopen.2024.0904","volume":"7","author":"CC-H Peng","year":"2024","unstructured":"C.C.-H. Peng, Y.-J. Lin, S.Y. Lee et al., MACE and hyperthyroidism treated with medication, radioactive iodine, or thyroidectomy. JAMA Netw. Open. 7, e240904 (2024). https:\/\/doi.org\/10.1001\/jamanetworkopen.2024.0904.","journal-title":"JAMA Netw. Open."},{"key":"4342_CR26","doi-asserted-by":"publisher","first-page":"1111","DOI":"10.1089\/thy.2017.0461","volume":"28","author":"E Ry\u00f6di","year":"2018","unstructured":"E. Ry\u00f6di, S. Metso, H. Huhtala et al., Cardiovascular morbidity and mortality after treatment of hyperthyroidism with either radioactive iodine or thyroidectomy. Thyroid 28, 1111\u20131120 (2018). https:\/\/doi.org\/10.1089\/thy.2017.0461.","journal-title":"Thyroid"},{"key":"4342_CR27","doi-asserted-by":"publisher","first-page":"761782","DOI":"10.3389\/fendo.2021.761782","volume":"12","author":"E Song","year":"2021","unstructured":"E. Song, M. Kim, S. Park et al., Treatment modality and risk of heart failure in patients with long-standing Graves\u2019 disease: A nationwide population-based cohort study. Front. Endocrinol. 12, 761782 (2021). https:\/\/doi.org\/10.3389\/fendo.2021.761782.","journal-title":"Front. Endocrinol."},{"key":"4342_CR28","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1530\/EJE-11-0299","volume":"165","author":"F Brandt","year":"2011","unstructured":"F. Brandt, A. Green, L. Heged\u00fcs, T.H. Brix, A critical review and meta-analysis of the association between overt hyperthyroidism and mortality. Eur. J. Endocrinol. 165, 491\u2013497 (2011). https:\/\/doi.org\/10.1530\/EJE-11-0299.","journal-title":"Eur. J. Endocrinol."},{"key":"4342_CR29","doi-asserted-by":"publisher","first-page":"2301","DOI":"10.1210\/jc.2017-00166","volume":"102","author":"M Lillevang-Johansen","year":"2017","unstructured":"M. Lillevang-Johansen, B. Abrahamsen, H.L. J\u00f8rgensen et al., Excess mortality in treated and untreated hyperthyroidism is related to cumulative periods of low serum TSH. J. Clin. Endocrinol. Metab. 102, 2301\u20132309 (2017). https:\/\/doi.org\/10.1210\/jc.2017-00166.","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"4342_CR30","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1007\/s12020-022-03193-7","volume":"79","author":"R Parameswaran","year":"2023","unstructured":"R. Parameswaran, M.C. de Jong, J.L.W. Kit et al., 2021 Asia-Pacific Graves\u2019 disease consortium survey of clinical practice patterns in the management of Graves\u2019 disease. Endocrine 79, 135\u2013142 (2023). https:\/\/doi.org\/10.1007\/s12020-022-03193-7.","journal-title":"Endocrine"},{"key":"4342_CR31","doi-asserted-by":"publisher","first-page":"1223","DOI":"10.1089\/thy.2016.0652","volume":"27","author":"F Azizi","year":"2017","unstructured":"F. Azizi, R. Malboosbaf, Long-Term antithyroid drug treatment: A systematic review and meta-analysis. Thyroid 27, 1223\u20131231 (2017). https:\/\/doi.org\/10.1089\/thy.2016.0652.","journal-title":"Thyroid"},{"key":"4342_CR32","doi-asserted-by":"publisher","first-page":"1545","DOI":"10.1089\/thy.2019.0085","volume":"29","author":"G Sj\u00f6lin","year":"2019","unstructured":"G. Sj\u00f6lin, M. Holmberg, O. T\u00f6rring et al., The long-term outcome of treatment for Graves\u2019 hyperthyroidism. Thyroid 29, 1545\u20131557 (2019). https:\/\/doi.org\/10.1089\/thy.2019.0085.","journal-title":"Thyroid"},{"key":"4342_CR33","doi-asserted-by":"publisher","first-page":"2956","DOI":"10.1210\/clinem\/dgae222","volume":"109","author":"D Villagelin","year":"2024","unstructured":"D. Villagelin, D.S. Cooper, H.B. Burch, A 2023 international survey of clinical practice patterns in the management of Graves disease: A decade of change. J. Clin. Endocrinol. Metab. 109, 2956\u20132966 (2024). https:\/\/doi.org\/10.1210\/clinem\/dgae222.","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"4342_CR34","doi-asserted-by":"publisher","first-page":"1032764","DOI":"10.3389\/fendo.2022.1032764","volume":"13","author":"YY Cho","year":"2022","unstructured":"Y.Y. Cho, B. Kim, D. Choi et al., Graves\u2019 disease, its treatments, and the risk of atrial fibrillation: A Korean population-based study. Front. Endocrinol. 13, 1032764 (2022). https:\/\/doi.org\/10.3389\/fendo.2022.1032764.","journal-title":"Front. Endocrinol."},{"key":"4342_CR35","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1016\/j.surg.2020.03.023","volume":"169","author":"A Elnahla","year":"2021","unstructured":"A. Elnahla, A.S. Attia, H.S. Khadra et al., Impact of surgery versus medical management on cardiovascular manifestations in Graves disease. Surgery 169, 82\u201386 (2021). https:\/\/doi.org\/10.1016\/j.surg.2020.03.023.","journal-title":"Surgery"},{"key":"4342_CR36","doi-asserted-by":"publisher","DOI":"10.1186\/s13044-020-00077-8","volume":"13","author":"OE Okosieme","year":"2020","unstructured":"O.E. Okosieme, P.N. Taylor, C.M. Dayan, Should radioiodine now be first line treatment for Graves\u2019 disease?. Thyroid. Res. 13, 3 (2020). https:\/\/doi.org\/10.1186\/s13044-020-00077-8.","journal-title":"Thyroid. Res."},{"key":"4342_CR37","first-page":"363","volume":"93","author":"I Kravets","year":"2016","unstructured":"I. Kravets, Hyperthyroidism: Diagnosis and treatment. Am. Fam. Physician 93, 363\u2013370 (2016).","journal-title":"Am. Fam. Physician"},{"key":"4342_CR38","doi-asserted-by":"publisher","first-page":"117955141984452","DOI":"10.1177\/1179551419844523","volume":"12","author":"M Smithson","year":"2019","unstructured":"M. Smithson, A. Asban, J. Miller, H. Chen, Considerations for thyroidectomy as treatment for Graves disease. Clin. Med. Insights Endocrinol. Diabetes 12, 1179551419844523 (2019). https:\/\/doi.org\/10.1177\/1179551419844523.","journal-title":"Clin. Med. Insights Endocrinol. Diabetes"}],"container-title":["Endocrine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12020-025-04342-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12020-025-04342-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12020-025-04342-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T04:00:49Z","timestamp":1758772849000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12020-025-04342-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,8]]},"references-count":38,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,10]]}},"alternative-id":["4342"],"URL":"https:\/\/doi.org\/10.1007\/s12020-025-04342-4","relation":{},"ISSN":["1559-0100"],"issn-type":[{"type":"electronic","value":"1559-0100"}],"subject":[],"published":{"date-parts":[[2025,7,8]]},"assertion":[{"value":"30 April 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 June 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 July 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}